Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioAdvance

Investor type Micro VC

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 192
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 87
Rounds per year 10.11
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.55
Exits 17
Key employees 5
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
Summary

BioAdvance appeared to be the VC, which was created in 2003. The company was established in North America in United States. The leading representative office of defined VC is situated in the Philadelphia.

Besides them, we counted 5 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the BioAdvance, startups are often financed by Ben Franklin Technology Partners of Southeastern Pennsylvania, Dorm Room Fund, Robin Hood Ventures. The meaningful sponsors for the fund in investment in the same round are Ben Franklin Technology Partners of Southeastern Pennsylvania, Safeguard Scientifics, iSeed Ventures. In the next rounds fund is usually obtained by Ben Franklin Technology Partners of Southeastern Pennsylvania, Safeguard Scientifics, Robin Hood Ventures.

Comparing to the other companies, this BioAdvance performs on 21 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2010. Speaking about the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 7-12 investment rounds annually. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2010. Despite it in 2019 the fund had an activity.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Advaxis, Wellsheet, Bainbridge Health Among the most popular fund investment industries, there are Health Diagnostics, Pharmaceutical. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioAdvance:
Typical Co-investors
BioAdvance is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioAdvance:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Senzo

Biotechnology
Health Care
Health Diagnostics
Information Technology
$2M21 Jul 2022 San Francisco, California, United States

Halo Labs

Analytics
Biopharma
Biotechnology
Health Diagnostics
Pharmaceutical
$6M11 Jul 2022 Philadelphia, Pennsylvania, United States

KayoThera

Biotechnology
Health Care
Medical
$8M16 Mar 2022 Princeton, New Jersey, United States

Phrase Health

Analytics
Health Care
Hospital
$3M28 Oct 2021 Philadelphia, Pennsylvania, United States

Wellsheet

Clinical Trials
Health Care
Hospital
Machine Learning
SaaS
Software
$3M11 Jun 2020 New York, United States

Palvella Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$45M28 May 2020 Radnor Township, Pennsylvania, United States

Halo Labs

Analytics
Biopharma
Biotechnology
Health Diagnostics
Pharmaceutical
$12M06 Apr 2020 Philadelphia, Pennsylvania, United States

Ride Health

Health Care
Transportation
$6M07 Jan 2020 New York, New York, United States

Renovacor

Biotechnology
$11M15 Aug 2019 Philadelphia, Pennsylvania, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioAdvance?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: